Analogous to previous studies in colon cancer showing direct interaction of VDR and β-catenin [32, 47], we found that active β-catenin had significantly less interaction with the cyclin D1 promoter after 1,25D3 treatment in mammary tumor cells. Here, CCND1 is linked to breast cancer.